Live Feed

DALLAS, May 1, 2026 /PRNewswire/ -- Toby Neugebauer, co-founder and largest shareholder of Fermi America (NASDAQ & LSE: FRMI), today announced that he has nominated Larry Kellerman to join the Fermi Board of Directors. Kellerman, who serves as Chief Power Officer at Fermi America, is the architect of the Company's 17-gigawatt powered data center campus in Amarillo, Texas — the largest private energy grid in America. Kellerman is co-founder and Managing Partner of Twenty First Century Utilities and brings more than four decades of power industry and finance expertise to the role. His career spans senior leadership positions at Goldman Sachs, El Paso Corporation, and I Squared Capital. Kellerm

4 - Laser Photonics Corp (0001807887) (Issuer)

4 - Commercial Bancgroup, Inc. (0001981546) (Issuer)

EAGLE, Idaho, May 01, 2026 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ:PNTG), the parent company of the Pennant group of affiliated home health, hospice, home care and senior living companies, announced today that effective May 1st 2026, it has assumed operations of three senior living communities across Arizona and Wisconsin, expanding Pennant's operations by 194 units. The three operations are all subject to triple net leases. In Glendale, Arizona, Pennant has assumed operations of a 100-unit assisted living community formerly known as Amarsi Senior Living, which will now operate as Saguaro Assisted Living. In Neenah, Wisconsin, Pennant has assumed operations of a 45-unit assist

TORONTO, May 1, 2026 /CNW/ - Agnico Eagle Mines Limited (NYSE:AEM) (TSX:AEM) ("Agnico Eagle") today announced that, at the annual and special meeting of shareholders held on May 1, 2026, the eleven candidates listed in the management information circular dated March 19, 2026 were duly elected as directors of Agnico Eagle.Detailed results of the vote are set out below:NomineeVotes ForVotes WithheldTotal Votes CastPercentage of Votes ForPercentage of Votes WithheldLeona Aglukkaq376,559,8873,993,239380,553,12698.95 %1.05 %Ammar Al-Joundi373,674,8926,878,232380,553,12498.19 %1.81 %Sean Boyd357,792,06622,761,060380,553,12694.02 %5.98 %Martine A. Celej370,994,3539,558,772380,553,12597.49 %2.51 %Jo

OMAHA, Neb., May 01, 2026 (GLOBE NEWSWIRE) -- Exodus Movement, Inc. (NYSE:EXOD) ("Exodus"), a leading self-custodial cryptocurrency platform, today announced that it has acquired the outstanding shares of Baanx US Corp. and certain other assets from W3C Corp. The purchase price for the transaction was $5 million payable upon the transfer of specified assets, with an additional $25 million in deferred consideration payable over four years. JP Richardson, CEO and Co-Founder of Exodus, commented, "In the last 24 hours, the pieces of the Baanx and Monavate acquisition have all come together. Closing the Baanx US deal is the final step. With Baanx US closed, we officially enter the next chapte

4 - ASSURED GUARANTY LTD (0001273813) (Reporting)

4 - AMREP CORP. (0000006207) (Issuer)

VANCOUVER, British Columbia, May 01, 2026 (GLOBE NEWSWIRE) -- Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company leveraging its proprietary Diffusphere™ technology designed to optimize local, controlled drug delivery for applications with significant unmet need, today announced the appointment of Dr. Jeymi Tambiah as Chief Medical Officer (CMO) as well as the retirement of Dr. Mark Kowalski, Eupraxia's current CMO. Dr. Jeymi Tambiah (MB ChB, FRCS, MS, FAPCR, FFPM), is a Board Certified Cardiothoracic Surgeon physician scientist who practiced at Guys and St Thomas' Hospitals prior to entering the biopharmaceutical in

Accendra Health, Inc. (NYSE:ACH) (the "Company") plans to release financial results for the first quarter of 2026 on Monday, May 11, 2026, before trading begins on the New York Stock Exchange. The Company will host a conference call for investors and analysts at 8:30 a.m. EDT on the same day. Participants may access the call via the toll-free dial-in number at 1-888-300-2035, or the toll dial-in number at 1-646-517-7437. The conference ID access code is 1058917. All interested stakeholders are encouraged to access the simultaneous live webcast by visiting the Investor Relations page of the Accendra Health website available at investors.accendra.com/events-and-presentations/. A replay of

OMAHA, Neb., May 01, 2026 (GLOBE NEWSWIRE) -- Exodus Movement, Inc. (NYSE:EXOD) ("Exodus"), a leading self-custodial cryptocurrency platform, today announced that it has acquired the outstanding shares of Monavate Holdings Limited, and Baanx.com Ltd., which were subsidiaries of W3C Corp ("W3C"), from the Receivers that were appointed in the United Kingdom to take control of these entities after W3C defaulted on a loan that was secured by these shares. The purchase price of these shares is $76.273.333.30, which is the exact amount of principal and interest outstanding on the W3C loan, as of April 30, 2026. Monavate Holdings Limited, together with its subsidiary Monavate Ltd and Baanx.com L

4 - Crane Co (0001944013) (Issuer)

NOVAGOLD's Annual General Meeting of Shareholders will be held virtually on May 14, 2026, at 1:00 p.m. PDTShareholders may vote on matters before the Meeting by proxy, join the virtual Meeting and vote, and submit questions either during the webcast or in advance by emailFollowing the Meeting, Chairman Dr. Thomas S. Kaplan and President and CEO Greg Lang will discuss the strategic case for gold and NOVAGOLD's role within the broader investment thesis, building on Dr. Kaplan's extensive commentary on gold as a strategic asset. They will also highlight the latest catalysts for the Donlin Gold project — a long-life, federally permitted U.S. asset with scale and extraordinary leverage to gold.

4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)

4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)

4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)

4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)

4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)

4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)

BOSTON, May 1, 2026 /PRNewswire/ - The John Hancock closed-end funds listed below declared their monthly distributions today as follows: Declaration Date:       May 1, 2026Ex Date:                     May 11, 2026Record Date:             May 11, 2026Payment Date:          May 29, 2026TickerFund NameDistribution Per Share Change From Previous DistributionMarket Price as of 4/30/2026Annualized Current Distribution Rate at MarketHPIPreferred Income Fund I$0.1235-$16.359.06 %HPFPreferred Income Fund II$0.1235-$16.089.22 %HPSPreferred Income Fund III$0.1100-$14.838.90 %PDTPremium Dividend Fund$0.0825-$13.237.48 %HTDTax-Advantaged Dividend Income Fund$0.1580-$25.947.31 %John Hancock Premium Divide